Close Menu

NEW YORK (GenomeWeb) – Boston-based startup Day Zero Diagnostics said today that it has raised $8.6 million in a Series A funding round.

DZD will use the funding to expedite prototype development of its sample preparation technology and computational approach. According to the firm, the funds will also help introduce DZD Lab Services, a set of sequencing-based diagnostic services to "help clinicians address critical infection situations and transmission events."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.